Wound Care Innovations signs distribution agreement with KOMED for CellerateRx

Jul 1 2010

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) announced an important milestone in its planned growth strategy.  Its wholly owned subsidiary Wound Care Innovations signed a distribution agreement with KOMED, LLC of Georgia for direct response advertising on television and niche online marketing of CellerateRx® in the United States.  TV Goods Holding Corporation (TV Goods), a subsidiary of H&H Imports, Inc., will produce and air the commercials marketing CellerateRx® in cooperation with KOMED, LLC. "KOMED is very excited about the opportunity to market and sell CellerateRx because it is very user friendly and represents a true advancement in collagen based wound care products.  CellerateRx should exceed expectations of both clinicians and patients in the wound healing process," stated Jeff Koblitz, President.

"Our management team is pleased to be working with KOMED and Kevin Harrington's team at TV Goods to be launching CellerateRx® directly to US consumers. We are all very excited about what this deal means for our company's top-line revenue expansion as we pursue retail channels in the United States," stated Ronald Mathis, Wound Care Innovations' Senior Vice President of Marketing and Sales.

Kevin Harrington, CEO of TV Goods, was quoted as saying, "I am so thrilled about working with CellerateRx. The opportunities are huge and offer tremendous revenue opportunities worldwide." Kevin Harrington is widely acknowledged as the pioneer and principal architect of the "infomercial" industry. Since producing the industry's first infomercial in the 1980s, Harrington has financed more than 500 product launches resulting in sales of more than $4 billion worldwide with 20 products reaching individual sales of over $100 million each, and creating dozens of millionaires.  Steve Rogai, President of TV Goods, also added, "We couldn't be more excited to partner with CellerateRx.  We love this product and are looking forward to a global launch and mass retail distribution."